The investigational transdermal delivery system, known as Xulane Lo, is designed to deliver 150mcg of norelgestromin and 17.5mcg of ethinyl estradiol per day.

Research and Development (R&D) Expenses: R&D expenses decreased to $5.8 million for the three months ended March 31, 2025, ...

Lupin receives US FDA approval for raltegravir tablets USP, 600 mg: Our Bureau, Mumbai Thursday, May 8, 2025, 17:25 Hrs [IST] Global pharma major Lupin Limited (Lupin) announced t ...

Qure advances its Huntington’s program toward accelerated approval as PTC Therapeutics reports strong Phase 2 results. Learn ...

Simo’s appointment may also hint at a broader productization push within OpenAI. Her background at Facebook and Instacart ...

Intellia will present additional data from the ongoing Phase 1/2 study in an oral presentation at the European Academy of ...

Operator: Good day and welcome to the CorMedix, Inc. First Quarter 2025 Financial Results Conference Call. All participants ...

State jobs are known for offering competitive benefits and enrollment in the nation’s largest public pension plan.

A common medication used to treat HIV and hepatitis B may offer unexpected protection against Alzheimer's disease.

On track to complete enrollment of the global Phase 3 HAELO study in hereditary angioedema (HAE) in the third quarter of 2025Dosed first patient in the global Phase 3 MAGNITUDE-2 study evaluating nexi ...

As part of the 10th Mediterranean Neuroscience Society Conference, we are excited to present this new collection of articles ...

A BC Supreme Court judge has issued an arrest warrant for a man who's accused of running a “campaign of harassment and ...